Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PAT Guidance Will Draw From Existing Electronic Records Guidances

This article was originally published in The Tan Sheet

Executive Summary

FDA plans to draw from existing guidances to clarify 21 CFR Part 11 electronic record/electronic signature requirements in its planned PAT guidance
Advertisement

Related Content

McClellan on PAT
McClellan on PAT
McClellan on PAT
Electronic Records Enforcement Relaxed During Part 11 Review, FDA Says
Electronic Records Enforcement Relaxed During Part 11 Review, FDA Says
Electronic Records Enforcement Relaxed During Part 11 Review, FDA Says
Critical Control Point Model In PAT Guidance Supported By Industry
FDA Risk-Based Part 11 Proposal Expected By February 2003
FDA Risk-Based Part 11 Proposal Expected By February 2003
FDA PAT Inspection Teams Being Formed: Further Training Set For Fall

Topics

Advertisement
UsernamePublicRestriction

Register

PS094706

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel